thiotepa has been researched along with Rheumatic Diseases in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menkes, CJ | 1 |
| Kahn, MF | 1 |
1 review available for thiotepa and Rheumatic Diseases
| Article | Year |
|---|---|
[The immunodepressive agents. II. Immunodepressive agents in rheumatic diseases].
Topics: Azathioprine; Chlorambucil; Humans; Immunosuppressive Agents; Rheumatic Diseases; Thiotepa | 1967 |
1 trial available for thiotepa and Rheumatic Diseases
| Article | Year |
|---|---|
Is there a place for chemical and radiation synovectomy in rheumatic diseases?
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Erbium; Gold Colloid, Radioact | 1979 |